Evidence-based·Updated November 16, 2026·How we grade evidence

Clonazepam

MedicationBenzodiazepine (prescription)

Clonazepam is a long-acting benzodiazepine for panic disorder and some seizure disorders. Two large placebo-controlled trials found it reduced panic attacks over 6 to 9 weeks, with 1 to 2 mg a day giving the best balance of benefit and side effects. The boxed warning covers opioids, abuse and addiction, and dependence with dangerous withdrawal. Cannabis is a high-severity supplement concern; passionflower and valerian are moderate ones.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with panic disorder, or adults and children with certain seizure disorders, treated by a prescriber

Common dosing range

Set by your prescriber. For panic disorder the label starts at 0.25 mg twice daily, with a target of 1 mg a day for most people and a maximum of 4 mg a day. For seizures in adults it starts at no more than 1.5 mg a day in three doses, up to a maximum of 20 mg a day

When to expect effects

Blood levels peak in 1 to 4 hours; the panic trials measured benefit after 6 to 9 weeks of treatment

Watch out for

Boxed warnings: profound sedation, slowed breathing, coma and death with opioids; abuse, misuse and addiction; and physical dependence, with withdrawal reactions that can be life-threatening if it is stopped suddenly or reduced quickly. Avoid alcohol. Contraindicated in significant liver disease and acute narrow-angle glaucoma.

What is it

Clonazepam is a prescription benzodiazepine and a Schedule IV controlled substance, sold as Klonopin and generic tablets. The Klonopin label approves it for panic disorder, with or without agoraphobia, in adults, and alone or as an add-on for certain seizure types (Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and absence seizures that have not responded to succinimides). Like all benzodiazepines it carries a boxed warning about use with opioids, about abuse, misuse and addiction, and about dependence and withdrawal reactions. Because it is a long-acting sedative, cannabis, passionflower and valerian are the main supplement concerns, and the label also tells patients to avoid alcohol.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have panic disorder or a seizure disorder and your prescriber recommends clonazepam (with a prescriber)
You and your prescriber have agreed on the lowest effective dose, regular reviews and a plan for tapering when it is time to stop (with a prescriber)
You can avoid alcohol and you do not take opioids, or your prescriber has weighed those risks with you (with a prescriber)

Probably skip if…

You take an opioid pain medicine, unless your prescriber decides other options are inadequate: the boxed warning covers this combination
You have significant liver disease, acute narrow-angle glaucoma or an allergy to benzodiazepines: the label lists these as contraindications
You want to keep using cannabis, passionflower, valerian or other sedating products alongside it without telling your prescriber
You want a long-term panic treatment without regular review: the label says use beyond 9 weeks has not been systematically studied, and a Cochrane review notes guidelines prefer SSRI antidepressants first

Evidence at a glance

panic disorder (short-term treatment)

Good Evidence
Effect
Moderate in short trials; fewer panic attacks than placebo at 1 mg a day or more
Best fit
Adults with panic disorder, with or without agoraphobia
Time
Measured after 6 weeks at a stable dose

panic disorder (benzodiazepines, pooled trials)

Limited Evidence
Effect
Moderate in short trials; risk ratio 1.65 for response versus placebo
Best fit
Adults with panic disorder in short-term treatment
Time
Short-term trials of weeks

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

panic disorder (short-term treatment)

Disease adjunct
Good Evidence

In a multicenter, fixed-dose trial, 413 people with panic disorder were randomized to placebo or clonazepam 0.5, 1, 2, 3 or 4 mg a day for 6 weeks after a 3-week dose increase. The published report found doses of 1 mg a day and higher equally effective at reducing panic attacks, 0.5 mg not clearly better than placebo, and 1 to 2 mg a day the best balance of benefit and tolerability; the Klonopin label's account of the same study says a significant difference from placebo was seen consistently only at 1 mg a day. A second trial of 438 adults using individually adjusted doses (0.25 to 4 mg a day) for 6 weeks found clonazepam better than placebo for the number of panic attacks, overall severity, phobic fear and avoidance, and anticipatory anxiety. Somnolence was the main side effect. In both trials a slow 7-week taper was tolerated, though symptoms partly returned.

Effect size
Moderate in short trials; fewer panic attacks than placebo at 1 mg a day or more
Time to effect
Measured after 6 weeks at a stable dose
Best fit
Adults with panic disorder, with or without agoraphobia
Less likely
People needing long-term treatment, which these 6- to 9-week trials did not test, and people with substance use problems

Bottom line: In two large short trials, clonazepam at 1 mg a day or more reduced panic attacks compared with placebo.

Evidence is mixed

For the fixed-dose study, the published abstract reports 1 mg a day and higher as equally effective, while the Klonopin label says a significant difference from placebo was seen consistently only at 1 mg a day and that 2, 3 and 4 mg a day were less effective and caused more side effects.

panic disorder (benzodiazepines, pooled trials)

Disease adjunct
Limited Evidence

A 2019 Cochrane review of 24 trials with 4,233 participants found benzodiazepines more likely than placebo to bring a response (risk ratio 1.65; about 4 people treated for one extra response) and remission (risk ratio 1.61), with fewer dropouts overall but more dropouts due to side effects (risk ratio 1.58). The reviewers rated the evidence low quality: the trials were short, often at high risk of bias, and did not examine dependence or withdrawal. They noted that guidelines recommend SSRI antidepressants first for panic disorder.

Effect size
Moderate in short trials; risk ratio 1.65 for response versus placebo
Time to effect
Short-term trials of weeks
Best fit
Adults with panic disorder in short-term treatment
Less likely
People wanting long-term treatment, where dependence and withdrawal were not measured

Bottom line: Pooled short trials suggest benzodiazepines help panic disorder, but the evidence is low quality.

Evidence is mixed

The reviewers note that guidelines recommend SSRI antidepressants first for panic disorder because of benzodiazepine dependence and withdrawal, which the pooled trials did not measure.

How it works

Clonazepam is thought to work by strengthening the activity of GABA, the brain's main calming signal, at the GABA-A receptor. This reduces panic attacks and seizures but also causes drowsiness, unsteadiness and slower thinking. It is almost completely absorbed, peaks in the blood 1 to 4 hours after a dose, and has a typical elimination half-life of 30 to 40 hours, so it builds up over several days of regular use. The liver breaks it down, partly through CYP3A enzymes. Two features shape its interactions. First, anything else that depresses the brain adds to its effect: alcohol, opioids, sleep medicines, sedating antihistamines, antipsychotics, other anticonvulsants and sedating herbs. Second, enzyme inducers such as phenytoin, carbamazepine, lamotrigine and phenobarbital lowered clonazepam levels by about 38%, and the label advises caution with CYP3A blockers such as oral antifungals (for example fluconazole), which may raise its levels.

How to take it

1. Typical dose
Your prescriber sets and adjusts the dose. Panic disorder in adults: the Klonopin label starts at 0.25 mg twice daily, raised after 3 days to the target of 1 mg a day for most people; the label says higher doses (2 to 4 mg a day) were less effective in its fixed-dose study and caused more side effects (the published report of that study found 1 mg a day and higher equally effective, with 1 to 2 mg a day the best balance of benefit and tolerability), though some people may benefit from up to 4 mg a day, increased in steps of 0.125 to 0.25 mg twice daily every 3 days. Seizure disorders in adults: the starting dose should not exceed 1.5 mg a day divided into three doses, increased by 0.5 to 1 mg every 3 days, to a maximum of 20 mg a day. Children with seizures are dosed by weight. Older adults usually start at the low end of the range.
2. Higher studied dose
The panic disorder maximum is 4 mg a day; the seizure maximum is 20 mg a day. In the panic trials, 1 mg a day was the minimum effective dose and 1 to 2 mg a day gave the best balance of benefit and tolerability.
3. Timing
Panic disorder: twice daily; the label says taking one dose at bedtime may reduce daytime sleepiness. Seizures: divided into three doses, with any larger dose at bedtime.
4. With food
The label says to swallow the tablets whole with water and gives no food instructions.
5. Split dosing
Usually split into two (panic disorder) or three (seizures) doses a day
6. How long to try
The label says effectiveness beyond 9 weeks for panic disorder has not been systematically studied, so a prescriber should regularly reassess it. Stopping is done with a gradual taper planned by your prescriber; for panic disorder the label describes lowering by 0.125 mg twice daily every 3 days. In people with seizures, abrupt stopping can also trigger more seizures or status epilepticus.

What to track

Drowsiness, unsteadiness, slurred speech or confusion, especially in older adults and after any new medicine or supplement
Slow or shallow breathing or being hard to wake, especially with opioids or alcohol (call emergency services)
New or worse depression, thoughts of self-harm or unusual changes in mood or behavior (tell your prescriber right away)
Seizures returning or changing pattern; the label says some people lose the anticonvulsant effect, often within 3 months
Do not drive or operate machinery until you know how clonazepam affects you

Bottom line: Your prescriber sets the dose and any taper; avoid alcohol, and treat sedating herbs and cannabis as extra sedatives.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Sleepiness (37% vs 10% on placebo in panic disorder trials)DizzinessPoor coordination and unsteadiness (ataxia)Slurred speechDepression and fatigueIncreased saliva

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Klonopin label says newborns of mothers who used benzodiazepines late in pregnancy have had sedation (breathing problems, sluggishness, low muscle tone) and withdrawal symptoms, and that published observational studies do not report a clear link between benzodiazepines and major birth defects. In rabbit studies, clonazepam caused malformations at doses similar to or below human doses. Newborns exposed during pregnancy or labor should be watched for sedation, breathing problems, low muscle tone, feeding problems and withdrawal. The label encourages enrolling in the North American Antiepileptic Drug Pregnancy Registry. Breastfeeding: clonazepam passes into breast milk, and there are reports of sedation, poor feeding and poor weight gain in infants exposed to benzodiazepines through milk. The label says to weigh the benefits of breastfeeding against the mother's need for the medicine, and to watch a breastfed infant for sedation, poor feeding and poor weight gain.

Interactions

AlcoholCritical

The Klonopin label tells patients to avoid alcohol and says alcohol may strengthen the sedating action of benzodiazepines; its Medication Guide warns that the combination can cause severe drowsiness, breathing problems, coma and death. Clonazepam's half-life is typically 30 to 40 hours, so the risk does not end when a dose wears off. No study has measured clonazepam with alcohol directly; the warning comes from the label. Ask your prescriber or pharmacist how this applies to you, do not stop clonazepam on your own to drink, and call emergency services for anyone who is hard to wake or breathing slowly.

Opioids (oxycodone, hydrocodone, codeine, tramadol, morphine, fentanyl, methadone, buprenorphine)Critical

Boxed warning: benzodiazepines with opioids may cause profound sedation, respiratory depression, coma and death. In a study of US veterans on opioid pain medicines, a current benzodiazepine prescription was linked to 3.86 times the risk of overdose death. The label limits the combination to people whose other options are inadequate, at the lowest doses for the shortest time.

Kava (Piper methysticum)High

Kavain, a main kava compound, strengthened GABA-A receptors in a lab study, the same calming system clonazepam acts on, so the two may add up to excessive sedation. A published case report describes coma in a patient who took kava with alprazolam, another benzodiazepine; no case with clonazepam itself has been published, and the Klonopin label does not name kava. Kava has also been linked to liver injury, and the label says clonazepam should not be used in significant liver disease. Avoid combining them unless your prescriber agrees, and do not stop clonazepam on your own to make room for an herb.

Cannabis and THC productsHigh

Cannabis can cause sedation and poor coordination, and the label for dronabinol, a prescription form of THC, lists benzodiazepines among drugs that add to its effect on driving and alertness. Direct evidence with clonazepam is lacking: in a lab study of 10 cannabis users, diazepam changed the effects of oral THC little, and CBD raised levels of the active metabolite of clobazam (another benzodiazepine) about 3-fold in the Epidiolex label, a CYP2C19 effect that may not apply to clonazepam. Do not drive after using both, and tell your prescriber about any cannabis or CBD use.

Other sedating medicines (barbiturates, sleep medicines, other anxiety medicines, antipsychotics, MAO inhibitors, tricyclic antidepressants, other anticonvulsants)High

The Klonopin label says these drugs can strengthen the sedating action of benzodiazepines, and that using several anticonvulsants together can increase sedating side effects. Tell every prescriber and your pharmacist that you take clonazepam before anything sedating is added, including over-the-counter sleep aids.

Passionflower (Passiflora incarnata)Moderate

Passionflower extract acted on the GABA system in lab and animal studies: its calming effect in mice was blocked by the benzodiazepine antagonist flumazenil, though in a test-tube study it did not bind the benzodiazepine site itself. A case report described tremor, dizziness and muscle fatigue in a man taking lorazepam, another benzodiazepine, with passionflower and valerian. Human evidence is limited, so treat it as a caution: the likely result is extra drowsiness. Ask your prescriber before using passionflower teas, supplements or sleep blends.

Valerian (including valerian tea)Moderate

Valerenic acid from valerian strengthened GABA-A receptors in lab studies, so valerian may add to clonazepam's sedation. Human evidence is limited: a case report described tremor, dizziness and muscle fatigue in a man taking lorazepam with valerian and passionflower, while in 12 healthy volunteers 14 nights of valerian raised alprazolam's peak level only slightly without changing overall exposure. Treat valerian as a second sedative and use it only if your prescriber agrees.

Enzyme inducers (phenytoin, carbamazepine, lamotrigine, phenobarbital) and oral antifungals such as fluconazoleModerate

The label says enzyme-inducing anticonvulsants lowered clonazepam levels by about 38%, and that oral antifungals and other CYP3A blockers should be used cautiously because they may raise clonazepam levels and effects. Clonazepam can also change phenytoin levels, so the label recommends monitoring them. Your prescriber decides on any dose change.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (3)

+ alcohol

critical

Clonazepam (Klonopin) and alcohol both slow the brain and breathing, and the Klonopin label says alcohol can strengthen the sedating action of benzodiazepines. Its Medication Guide warns that benzodiazepines taken with alcohol can cause severe drowsiness, breathing problems, coma and death, and the label tells patients to avoid alcohol. The evidence is the FDA label and class warnings rather than a clonazepam plus alcohol study, and because clonazepam's half-life is typically 30 to 40 hours, the risk does not end when a dose wears off.

+ kava

high

Kavain, a main compound in kava, strengthened GABA-A receptors in a lab study, the same calming system clonazepam acts on, so the two may add up to excessive sedation. The only human report is a published case of coma in a patient who combined kava with alprazolam, another benzodiazepine; we found no case or study with clonazepam itself, and the Klonopin label does not name kava. Kava has also been linked to liver injury in a small number of reported cases.

+ passionflower

moderate

Clonazepam is a benzodiazepine that calms the brain by enhancing GABA, its main inhibitory neurotransmitter. Passionflower extract acted on the GABA system in lab and animal studies (its calming effect in mice was blocked by flumazenil, which blocks the benzodiazepine site), so it may add to clonazepam's sedation. The only human report is a case of tremor, dizziness and muscle fatigue in a man taking lorazepam, another benzodiazepine, with passionflower and valerian; no case with clonazepam has been published, so this is best treated as a caution rather than a proven hazard.

See all 3 Clonazepam interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Dispensed only on prescription by a licensed pharmacy; clonazepam is a Schedule IV controlled substance
Klonopin tablets of 0.5 mg (scored), 1 mg and 2 mg, swallowed whole with water
A Medication Guide must be given with each fill; it warns about opioids, alcohol and other sedating products
Store it securely and dispose of unused tablets properly, as the label advises

Be skeptical of…

Online sellers or social media offering "Klonopin" without a prescription or outside a licensed pharmacy
Calming herbal blends with passionflower, valerian or kava marketed as safe to take with a benzodiazepine
Advice to stop clonazepam suddenly or replace it with a supplement on your own: the label warns abrupt stopping can cause life-threatening withdrawal and, in epilepsy, status epilepticus

Frequently asked questions

Can I take passionflower or valerian with clonazepam?⌄

Ask your prescriber first. This page rates both moderate: each herb appears to act on the brain's GABA calming system, and a case report linked the pair to tremor and dizziness in a man taking lorazepam, another benzodiazepine. The likely result is extra drowsiness.

Is it safe to use cannabis or CBD with Klonopin?⌄

It is best avoided unless your prescriber agrees. Cannabis adds sedation and poor coordination, so do not drive after using both. Direct studies with clonazepam are lacking. Tell your prescriber about any cannabis or CBD use.

Can I drink alcohol while taking clonazepam?⌄

The Klonopin label says to avoid alcohol. Its Medication Guide warns that benzodiazepines taken with alcohol or other sedating drugs can cause severe drowsiness, breathing problems, coma and death.

How long does clonazepam stay in the body?⌄

Its elimination half-life is typically 30 to 40 hours, so it builds up over several days and wears off slowly. That is one reason sedation can carry into the next day, especially in older adults.

Can I stop taking clonazepam on my own?⌄

The boxed warning says abrupt stopping or a rapid dose reduction after continued use can cause withdrawal reactions, including seizures, that can be life-threatening. Your prescriber can plan a gradual taper if a change is needed.

References by claim

panic disorder (short-term treatment)

Rosenbaum et al., 1997 · PubMed (1997) link

Moroz et al., 1999 · PubMed (1999) link

panic disorder (benzodiazepines, pooled trials)

Breilmann et al., 2019 · PMC (2019) link

Safety

Klonopin (clonazepam) tablets prescribing information and Medication Guide · DailyMed (FDA label) link

FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class · FDA Drug Safety Communication link

Interaction: Kava (Piper methysticum)

Chua et al., 2016 · PMC (2016) link

Almeida et al., 1996 · PubMed (1996) link

Teschke et al., 2010 · PubMed (2010) link

Interaction: Cannabis and THC products

Syndros (dronabinol) oral solution prescribing information · DailyMed (FDA label) link

Lile et al., 2014 · PMC (2014) link

Epidiolex (cannabidiol) oral solution prescribing information · DailyMed (FDA label) link

Interaction: Passionflower (Passiflora incarnata)

Grundmann et al., 2008 · PubMed (2008) link

Appel et al., 2011 · PubMed (2011) link

Carrasco et al., 2009 · PubMed (2009) link

Interaction: Valerian (including valerian tea)

Khom et al., 2007 · PubMed (2007) link

Donovan et al., 2004 · PubMed (2004) link

Kelber et al., 2014 · PMC (2014) link

Interaction: Opioids (oxycodone, hydrocodone, codeine, tramadol, morphine, fentanyl, methadone, buprenorphine)

Park et al., 2015 · PMC (2015) link

Track Clonazepam with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.